Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2025 Apr 4;207(5):e00078-25. doi: 10.1128/jb.00078-25

Bacillus subtilis MurJ and Amj Lipid II flippases are not essential for growth

Kiera Englehart 1, Jonathan Dworkin 1,
Editor: George O'Toole2
PMCID: PMC12096821  PMID: 40183557

ABSTRACT

Identification of the protein that mediates transbilayer transport of the undecaprenyl-pyrophosphate (Und-PP) linked peptidoglycan precursor Lipid II has long been a subject of investigation. Candidates belonging to both the MOP (multidrug/oligosaccharidyl-lipid/polysaccharide) and SEDS (shape, elongation, division and sporulation) families of transmembrane proteins have been proposed, exhibiting characteristics consistent with mediating this process, including genetic essentiality and biochemical activity. While MOP family proteins including MurJ are widely considered to be the primary Lipid II transporter, questions still remain including a role for the SEDS proteins in this process. We and others previously showed that a Bacillus subtilis strain lacking all four MurJ homologs is viable, thereby implicating a separate mode of Lipid II transport across the membrane. However, a subsequent report of synthetic essentiality between B. subtilis MurJ and the flippase Amj suggested that they are necessary and sufficient. Here, we show that this effect is alleviated by excess synthesis of the enzyme responsible for Und-PP production. Thus, the inviability of a murJ-amj double mutant strain is not due to the essentiality of these enzymes for flipping Lipid II but is instead most likely a consequence of a reduction of free Und-PP levels. This result is consistent with a non-MOP-dependent pathway for Lipid II transport across the cytoplasmic membrane to enable cell wall peptidoglycan synthesis.

IMPORTANCE

The assembly of peptidoglycan (PG), the typically essential polymer that provides structural integrity to bacterial cells, begins with the synthesis of the Lipid II monomer in the cytoplasm and along the cytoplasmic face of the inner membrane. Lipid II is then translocated across the membrane to the extracellular site of polymerization. The mechanistic basis for this process remains unclear, with genetic and/or biochemical evidence pointing to two different families of conserved membrane proteins. Here, we present genetic evidence that only one of these two families is essential in Bacillus subtilis.

KEYWORDS: peptidoglycan

INTRODUCTION

The mesh-like extracellular peptidoglycan (PG) sacculus provides structural integrity to bacterial cells. As such, PG is typically essential for growth, although under special conditions, bacteria lacking PG can survive. PG is a glycopeptide polymer composed of units of repeating GlcNAc–MurNAc disaccharides covalently attached to stem peptides. The monomeric units are synthesized initially in the cytoplasm and in the final steps, along the cytoplasmic face of the membrane, as a molecule known as Lipid II that contains the glycopeptide attached to a 55-carbon isoprenoid, undecaprenol-pyrophosphate (Und-PP). Lipid II is then transported to the outside of the cell membrane, the site of the transglycosylation (TG) and transpeptidation (TP) activities that assemble the PG polymer (1). These reactions are mediated by two classes of enzymes, the bifunctional class A PBPs, which exhibit both TG and TP activities, and the class B PBPs, which exhibit only TP activity, working in tandem with a SEDS (shape, elongation, division and sporulation) protein with TG activity (2).

The molecular mechanism underlying Lipid II transport remained uncharacterized long after the identification of the enzymes responsible for Lipid II synthesis and polymerization. Integral membrane proteins of the SEDS family are long-hypothesized candidates. The well-studied essential cell division protein SEDS protein FtsW exhibits activity in a fluorescence-based proteoliposome assay consistent with a role in Lipid II transport (3, 4). A second candidate is an essential Escherichia coli protein initially known as MviN (5) and subsequently renamed MurJ (6), a member of the MOP (multidrug/oligosaccharidyl-lipid/polysaccharide) family. Experiments using an in vivo assay based on the accessibility of translocated Lipid II to cleavage by a degradative enzyme are consistent with a function for MurJ in Lipid II transport in E. coli (7). However, B. subtilis MurJ and its three homologs are not essential either separately or together (8, 9), raising the question of whether the essential function of MurJ as the Lipid II flippase was phylogenetically conserved. A synthetic lethal screen identified a gene (amj) that was synthetically lethal with B. subtilis murJ (10). However, Amj has no sequence or predicted structural homology to MurJ (10), so the question remains as to why B. subtilis MurJ, unlike E. coli MurJ, is not essential. Here, we set out to investigate the origin of this difference.

RESULTS

The original characterization of E. coli MurJ (MviN) reported that the growth defect of a mviN temperature-sensitive mutation at the non-permissive temperature was suppressed by overexpression of the undecaprenyl pyrophosphate synthase (UppS) (5). This observation suggests that MurJ-associated phenotypes in B. subtilis might also be subject to suppression by UppS overexpression. To examine this possibility, we determined if additional Und-PP would affect the phenotype of the murJ/amj depletion strain. First, we introduced an inducible allele of uppS [(Physpank−uppS) (11)] into a strain lacking murJ alone [∆murJ::spc, as derived from the published strain (10)]. Of note, this strain is wildtype with respect to endogenous uppS, so induced uppS results in levels of Und-PP that are supplemental. We made this strain competent and introduced the amj deletion allele (∆amj::mls), plating transformants on a selective medium in the presence of an inducer (IPTG). We obtained transformants at a normal transformation frequency and confirmed the presence of the correct murJ and amj alleles by genome sequencing and backcrossing. Consistent with a requirement for uppS expression, colonies were not recovered in the absence of inducer. We then grew one of these transformants (JDB4540; murJ::spec amyE::Physpank-uppS (cat) amj::mls) in the presence or absence of an inducer, observing that growth was dependent on the presence of an inducer (Fig. 1A). Consistent with the restoration of growth, cells exhibited wild-type morphology in the presence of an inducer including the absence of lysed (yellow) and bulging (red) cells seen without inducer (Fig. 1B). The effect of UppS overexpression on growth is quantitatively dependent on inducer concentration (Fig. 1C), consistent with increased availability of Und-PP mediating the restoration of growth.

Fig 1.

The graph presents OD over time for bacterial strains with and without inducer. Microscopy depicts bacterial morphology with and without inducers, highlighting differences in cell shape. The growth curve illustrates OD changes at varying inducer concentrations.

Overexpression of uppS restores viability of double mutant ∆murJamj strain. (A) Strain JDB4540 (∆murJ ∆amj amyE::Physpank–uppS) was grown in LB in the presence (squares) or absence of 1 mM IPTG (circles) and OD600 was recorded. Shown is an example of one of three biological replicates. (B) Samples of the cultures in A obtained at time point t = 90 min were examined by microscopy as described. Lysed (yellow arrow) and morphologically distorted (red arrow) cells are noted. (C) Dose-response rescue of ∆murJamj strain by uppS overexpression. Strain JDB4540 was grown in LB in the absence (black) or the presence of a range of IPTG concentrations (blue hues) and OD600 was determined. Shown is one example, and biological replicates exhibited similar patterns of growth.

We then examined whether the effect of additional UppS expression on the viability of cells lacking MurJ and Amj would be observed under another condition where MurJ homologs are essential for PG synthesis. We investigated the synthesis of the spore cortex PG where the sporulation-specific MurJ homolog spoVB is required, and a spoVB mutant strain is completely asporogenous (12). We sporulated spoVB mutant cells containing an inducible uppS allele in the presence or absence of an inducer and monitored sporulation efficiency. As expected, a severe reduction in sporulation was observed in the absence of an inducer. However, the presence of an inducer did not attenuate this defect (Table 1).

TABLE 1.

Effect of UppS overexpression on the spoVB sporulation phenotypea

Strain Sporulation
trpC2 100%
∆spoVB <10−5
∆spoVB Pspac-uppS (-IPTG) <10−5
∆spoVB Pspac-uppS (+IPTG) <10−5
a

Shown is one example of three biological replicates that all exhibit similar results.

Why is Und-PP supplementation successful in rescuing MurJ homolog function during growth but not during sporulation? Of potential relevance to this question is the strict requirement for class A PBP (aPBP) function in sporulation (13) but not B. subtilis growth (14, 15). Thus, if aPBP essentiality determines the effectiveness of Und-PP complementation of ∆murJ homologs, then aPBPs and MurJ may be functionally related. If so, the absence of aPBP would affect ∆murJ phenotypes. To test this hypothesis, we generated a strain lacking all aPBPs [ponA::kan; ∆pbpDFG (16)] and carrying deletions of both murJ and amj and an inducible amj allele. In the presence of an inducer, both this strain and a strain wildtype for aPBPs grew similarly (Fig. 2A). In the absence of an inducer, both strains exhibited a pronounced decrease in growth rate within 60 min. However, examination of the two strains by light microscopy revealed that the absence of aPBPs substantially mitigated the aberrant morphology of the murJ/amj strain observed in the absence of inducer (Fig. 2B). Thus, aPBP activity is functionally associated with murJ and amj.

Fig 2.

The graph presents OD over time for bacterial strains under different conditions. Microscopy depicts bacterial morphology with and without inducer in two strains, with differences in cell clustering and shape. Growth patterns vary based on genetic background.

Absence of aPBPs partially suppresses the phenotype of the ∆murJamj strain. (A) Strain JDB4181 (blue; ∆murJamj Pspank*-amj) and JDB4493 (green; ∆pbpDFG ΔponA ∆murJ ∆amj Pspank*-amj) were grown in LB in the presence or absence of inducer (1 mM IPTG), and OD600 was determined. (B) Samples of the cultures in A were examined by microscopy at time point t = 120 min as described. Shown is one example, and biological replicates exhibited similar patterns of growth.

DISCUSSION

We find that the previously reported inviability of a B. subtilis strain containing mutations in both murJ and amj (10) is not due to their synergistic essentiality. We show that supplemental expression of UppS, the cytoplasmic enzyme responsible for the synthesis of Und-PP, allows this strain to grow despite the absence of MurJ and Amj, consistent with a separate system for Lipid II export. Thus, these mutations likely lead to inviability because together they reduce the levels of free Und-PP below that needed for PG synthesis during growth, possibly as a consequence of Und-PP sequestration. This result implies that MurJ and Amj cannot be the sole enzymes mediating the process of Lipid II membrane translocation necessary for PG synthesis during growth in B. subtilis.

We further demonstrate that the elimination of aPBP function partially suppresses the phenotype of a murJ/amj double mutant. This effect suggests that the non-essentiality of B. subtilis MurJ is due to the non-essentiality of aPBP function for B. subtilis growth. While the loss of aPBP function does alleviate the dramatic morphological pathologies exhibited by cells depleted for murJ/amj, it does not allow for growth and division. Why this suppression is only partial is not clear, although since a strain lacking aPBPs is viable but phenotypically distinct from the wild-type parent (17), there could be a synergistic interaction between the two classes of mutations. In addition, we observe that UppS supplementation does not suppress the sporulation deficiency of a strain lacking the sporulation-specific MurJ homolog SpoVB. Since PG synthesis in sporulation requires aPBP function (13), UppS-dependent suppression may, therefore, only occur in contexts where aPBP-mediated PG synthesis is not essential. It is formally possible that increased levels of Und-PP affect the activity and/or expression of the other non-sporulation-specific MurJ homolog YabM.

The suppression of morphological defects of the murJ/amj mutant strain observed in the absence of aPBPs suggests that MurJ (and possibly Amj) are involved in aPBP-dependent PG synthesis. MurJ is a Lipid II binding protein (18), so it could mediate the transport of cytosolically produced Lipid II used by the aPBPs. (Fig. 3, left). Since growing evidence indicates that aPBP enzymes function separately from the SEDS-family protein complexes containing bPBPs (2, 19), MurJ would then functionally associate with aPBP-containing PG synthetic complexes. This association is likely not mediated by specific protein–protein interactions, as B. subtilis Amj can functionally substitute for E. coli MurJ, despite the fact that they are not homologs (10).

Fig 3.

The diagram presents bacterial cell wall biosynthesis with Lipid II translocation across the membrane by MurJ and polymerization into the peptidoglycan layer through aPBP, bPBP, and SEDS. Membrane-bound proteins facilitate Lipid II incorporation.

Model of MurJ/Amj function during PG synthesis. Lipid II synthesized on the cytoplasmic face of the membrane is flipped either by MurJ for use by an aPBP (dual TG/TP) or by RodA for use by RodA(TG) and bPBP(TP).

Our observations could help resolve the apparent paradox of two different proteins—MurJ and FtsW—being identified as Lipid II flippases. E. coli MurJ is essential (5, 6) and murJ mutations reduce Lipid II accessibility on the extracellular surface of the cytoplasmic membrane (7). E. coli FtsW is also essential, and experiments directly monitoring the movement of fluorescent Lipid II across model membranes observed an FtsW-dependence (3, 4). MurJ (20) and FtsW (21) (and its SEDS homolog RodA [2224]) enzymes have been investigated structurally, but to date, a flippase mechanism has not been definitively established. While MurJ and SEDS proteins could function together in translocating Lipid II (1), an alternative model consistent with the data presented here for B. subtilis is that they work with separate PG synthesizing pathways, one containing a SEDS protein (either FtsW or RodA) that flips Lipid II in association with its cognate bPBP and the other including MurJ that flips Lipid II used by an aPBP (Fig. 3).

SEDS proteins have essential TG activity (25), proposed to be coupled to flippase activity (1). Given the intimate nature of the interaction between the TG activity of the SEDS protein and the TP activity of the bPBP (22, 24), it is not clear how Lipid II flipped by a SEDS protein would be made available to aPBPs that are not part of the SEDS-bPBP complex (2, 26). In addition, SEDS proteins likely function as part of a large biosynthetic complex that, as proposed, includes enzymes of the Lipid II synthesis pathway (27, 28). For example, the E. coli Lipid II synthase MurG interacts with PBP3, the partner of FtsW (29), and MurG forms a complex with the Lipid I synthase MraY (29) as well as the MurE and MurF enzymes (30). Thus, an appealing aspect of the proposed mechanism is that it would facilitate Lipid II availability for aPBP-dependent PG biosynthesis pathways. That is, MurJ-dependent translocation of Lipid II produced by Mur enzymes functioning independently of the SEDS-bPBP complex would allow both aPBP and bPBP pathways to simultaneously synthesize PG.

The observation reported here regarding murJ/amj inviability has parallels in prior work addressing the apparent essentiality of other genes later found to be non-essential. For example, strains carrying knockouts in various teichoic acid biosynthetic genes encoding enzymes active in the later steps of the pathway are not viable, suggesting that teichoic acid is essential (31). However, the deletion of tagO that encodes the enzyme mediating the initial step in teichoic acid biosynthesis, the attachment of UDP-GlcNAc to Und-PP, allows for the deletion of later genes in the pathway (32), suggesting that the inviability of tag mutant strains is a consequence of Und-PP sequestration away from PG synthesis. In the present context, the alleviation of murJ/amj synthetic lethality by UppS expression would also result from Und-PP sequestration. While the mechanistic basis of this sequestration is unclear, the phenomenon of Und-PP pools being subject to competition by different cellular processes with PG synthesis is well characterized. For example, enterobacterial O-antigen synthesis also requires Und-PP, and disrupting O-antigen synthesis results in cell shape deformities suppressed by supplemental Und-PP expression (33). Again, the specific mechanism underlying Und-PP sequestration in this context is unclear. Mutation of an enzyme mediating enterobacterial common antigen (ECA) biosynthesis caused defects in cell shape that were suppressed by increasing Und-PP levels. In this case, sequestration was attributed to the accumulation of the Und-PP-1-linked intermediate ECA-lipid II (34).

Tight regulation of Und-PP pools is evolutionarily conserved (35, 36). This may be a consequence of the phenomenon that an overabundance of membrane-associated polyisoprenols, particularly an extended C-55 polyprenol like Und-PP, can disrupt the phospholipid bilayer architecture (37), thereby restricting the size of Und-PP pools. Given this constraint, any Und-PP-consuming pathway must function so as to not interfere with the Und-PP pool required for optimal PG synthesis, a rate-limiting step in bacterial growth (38). Recent work demonstrated the key role of the extracellular sigma factor SigM in maintaining this homeostasis (39). Such metabolic coordination is presumably characteristic of normal physiological contexts and may become particularly relevant to a more pathological context such as a mutation in one of these pathways (34). The observations presented here suggest that mutations affecting a non-essential PG biosynthetic pathway such as that mediated by aPBPs in B. subtilis can similarly affect essential bPBP-dependent PG synthesis.

In summary, this work is most consistent with a model for B. subtilis PG biosynthesis in which the MurJ and/or Amj Lipid II flippases support normal growth but are not absolutely essential, and SEDS Lipid II flippases participate in essential elongasome and divisome function. Thus, the MOP and SEDS systems may provide a dual route for Lipid II export to the outer face of the cytoplasmic membrane, as postulated (28).

MATERIALS AND METHODS

Bacterial growth and sporulation

Strains were grown in Lysogeny Broth (LB) with shaking at 37°C. For measurement of growth curves, an overnight culture from a single freshly streaked colony in the mid-log phase (OD600 ~0.3) was diluted 1:10 in 10 mL LB and grown to mid-log. The culture was centrifuged (5′, 3,000 rpm), the pellet was washed in pre-warmed LB, and resuspended in 2 mL LB. One mL was added to a flask containing 9 mL LB and one mL to a flask with 9 mL LB with IPTG as noted. For sporulation, strains were grown in Difco Sporulation Media (DSM) for 24 h at 37°C on a roller-drum, with 1 mM IPTG as noted. Sporulation efficiency was determined by measuring colony-forming units on LB plates before and after heating to 80°C for 15 min and is calculated relative to the efficiency of the wild-type parent.

Strain construction

Strains were derived from B. subtilis 168 trpC2 and are listed in Table 2. Strains were constructed by transformation using conventional methodology, and where necessary, media was supplemented with 100 µg/mL spectinomycin, 10 µg/mL kanamycin, 5 µg/mL chloramphenicol, and 1× MLS or 20 mM MgCl2 (for strains carrying aPBP mutations). JDB4540 was constructed by transforming JDB4005 gDNA into a murJ::spc strain (derived from JDB4181), selecting for cmR. The resulting strain was transformed with JDB4181 gDNA, selecting for mlsR in the presence of 1 mM IPTG. JDB4493 was constructed by transforming JDB4181 gDNA into JDB4482, selecting for specR. This strain was transformed with JDB4181 gDNA selecting for cmR. The resulting strain was transformed with JDB4181 gDNA, selecting for mlsR in the presence of IPTG. Finally, JDB4443 gDNA was transformed into this strain, selecting for kanR in the presence of IPTG. JDB4547 was constructed by transforming JDB4006 gDNA into JDB1097, selecting for cmR.

TABLE 2.

Strains

Strain Genotype Source
JDB1772 trpC2 Lab collection
JDB1097 spoVBΔ::tet Lab collection
JDB4005 W168 kan::uppS1 amyE::Pspac(hy)-uppS-FLAG (cat) (11)
JDB4181 ycgO::Pspank*-amj(cat) murJ::spec amj::mls sacA::Pveg-mcherry(tet) (10)
JDB4540 murJ::spec amyE::Physpank−uppS (cat) amj::mls This work
JDB4443 ponA::kan Bacillus subtilis Genetic Stock Center
JDB4482 ∆pbpDFG Helmann lab
JDB4493 ∆pbpDFG ytgP::spec ycgO::Pspank*-ydaH(cat) ydaH::mls ΔponA::kan This work
JDB4547 spoVBΔ::tet amyE::Pspac(hy)-uppS (cat) This work

Microscopy

Cells were immobilized on 1% agar pads in PBS. Phase contrast microscopy was performed using a Nikon Eclipse 90i microscope and a CFI Plan Apo 100×, NA 1.45 oil objective. Images were taken with a Hamamatsu Orca ER-AG camera and processed with ImageJ.

ACKNOWLEDGMENTS

K.E. and J.D. were supported by NIH R35GM141953. We thank David Roper and members of our laboratory for their comments on the manuscript. Figure 3 was made with the assistance of Biorender. Strains were generously provided by John Helmann and David Rudner.

Footnotes

This article was submitted via the Active Contributor Track (ACT). Jonathan Dworkin, the ACT-eligible author, secured reviews from David L. Popham, Virginia Polytechnic Institute and State University, and Dirk-Jan Scheffers, University of Groningen.

Contributor Information

Jonathan Dworkin, Email: jonathan.dworkin@columbia.edu.

George O'Toole, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.

REFERENCES

  • 1. Egan AJF, Errington J, Vollmer W. 2020. Regulation of peptidoglycan synthesis and remodelling. Nat Rev Microbiol 18:446–460. doi: 10.1038/s41579-020-0366-3 [DOI] [PubMed] [Google Scholar]
  • 2. Straume D, Piechowiak KW, Kjos M, Håvarstein LS. 2021. Class A PBPs: it is time to rethink traditional paradigms. Mol Microbiol 116:41–52. doi: 10.1111/mmi.14714 [DOI] [PubMed] [Google Scholar]
  • 3. Mohammadi T, van Dam V, Sijbrandi R, Vernet T, Zapun A, Bouhss A, Diepeveen-de Bruin M, Nguyen-Distèche M, de Kruijff B, Breukink E. 2011. Identification of FtsW as a transporter of lipid-linked cell wall precursors across the membrane. EMBO J 30:1425–1432. doi: 10.1038/emboj.2011.61 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Mohammadi T, Sijbrandi R, Lutters M, Verheul J, Martin NI, den Blaauwen T, de Kruijff B, Breukink E. 2014. Specificity of the transport of lipid II by FtsW in Escherichia coli. J Biol Chem 289:14707–14718. doi: 10.1074/jbc.M114.557371 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Inoue A, Murata Y, Takahashi H, Tsuji N, Fujisaki S, Kato J. 2008. Involvement of an essential gene, mviN, in murein synthesis in Escherichia coli. J Bacteriol 190:7298–7301. doi: 10.1128/JB.00551-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Ruiz N. 2008. Bioinformatics identification of MurJ (MviN) as the peptidoglycan lipid II flippase in Escherichia coli. Proc Natl Acad Sci USA 105:15553–15557. doi: 10.1073/pnas.0808352105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Sham LT, Butler EK, Lebar MD, Kahne D, Bernhardt TG, Ruiz N. 2014. Bacterial cell wall. MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis. Science 345:220–222. doi: 10.1126/science.1254522 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Fay A, Dworkin J. 2009. Bacillus subtilis homologs of MviN (MurJ), the putative Escherichia coli lipid II flippase, are not essential for growth. J Bacteriol 191:6020–6028. doi: 10.1128/JB.00605-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Vasudevan P, McElligott J, Attkisson C, Betteken M, Popham DL. 2009. Homologues of the Bacillus subtilis SpoVB protein are involved in cell wall metabolism. J Bacteriol 191:6012–6019. doi: 10.1128/JB.00604-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Meeske AJ, Sham LT, Kimsey H, Koo BM, Gross CA, Bernhardt TG, Rudner DZ. 2015. MurJ and a novel lipid II flippase are required for cell wall biogenesis in Bacillus subtilis. Proc Natl Acad Sci USA 112:6437–6442. doi: 10.1073/pnas.1504967112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Lee YH, Helmann JD. 2013. Reducing the level of undecaprenyl pyrophosphate synthase has complex effects on susceptibility to cell wall antibiotics. Antimicrob Agents Chemother 57:4267–4275. doi: 10.1128/AAC.00794-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Popham DL, Stragier P. 1991. Cloning, characterization, and expression of the spoVB gene of Bacillus subtilis. J Bacteriol 173:7942–7949. doi: 10.1128/jb.173.24.7942-7949.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. McPherson DC, Driks A, Popham DL. 2001. Two class A high-molecular-weight penicillin-binding proteins of Bacillus subtilis play redundant roles in sporulation. J Bacteriol 183:6046–6053. doi: 10.1128/JB.183.20.6046-6053.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Popham DL, Setlow P. 1996. Phenotypes of Bacillus subtilis mutants lacking multiple class A high-molecular-weight penicillin-binding proteins. J Bacteriol 178:2079–2085. doi: 10.1128/jb.178.7.2079-2085.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. McPherson DC, Popham DL. 2003. Peptidoglycan synthesis in the absence of class A penicillin-binding proteins in Bacillus subtilis. J Bacteriol 185:1423–1431. doi: 10.1128/JB.185.4.1423-1431.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Patel Y, Zhao H, Helmann JD. 2020. A regulatory pathway that selectively up-regulates elongasome function in the absence of class A PBPs. Elife 9:e57902. doi: 10.7554/eLife.57902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Murray T, Popham DL, Setlow P. 1998. Bacillus subtilis cells lacking penicillin-binding protein 1 require increased levels of divalent cations for growth. J Bacteriol 180:4555–4563. doi: 10.1128/JB.180.17.4555-4563.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Bolla JR, Sauer JB, Wu D, Mehmood S, Allison TM, Robinson CV. 2018. Direct observation of the influence of cardiolipin and antibiotics on lipid II binding to MurJ. Nature Chem 10:363–371. doi: 10.1038/nchem.2919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Cho H, Wivagg CN, Kapoor M, Barry Z, Rohs PDA, Suh H, Marto JA, Garner EC, Bernhardt TG. 2016. Bacterial cell wall biogenesis is mediated by SEDS and PBP polymerase families functioning semi-autonomously. Nat Microbiol 1:16172. doi: 10.1038/nmicrobiol.2016.172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Kuk ACY, Mashalidis EH, Lee S-Y. 2017. Crystal structure of the MOP flippase MurJ in an inward-facing conformation. Nat Struct Mol Biol 24:171–176. doi: 10.1038/nsmb.3346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Käshammer L, van den Ent F, Jeffery M, Jean NL, Hale VL, Löwe J. 2023. Cryo-EM structure of the bacterial divisome core complex and antibiotic target FtsWIQBL. Nat Microbiol 8:1149–1159. doi: 10.1038/s41564-023-01368-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Sjodt M, Rohs PDA, Gilman MSA, Erlandson SC, Zheng S, Green AG, Brock KP, Taguchi A, Kahne D, Walker S, Marks DS, Rudner DZ, Bernhardt TG, Kruse AC. 2020. Structural coordination of polymerization and crosslinking by a SEDS-bPBP peptidoglycan synthase complex. Nat Microbiol 5:813–820. doi: 10.1038/s41564-020-0687-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Sjodt M, Brock K, Dobihal G, Rohs PDA, Green AG, Hopf TA, Meeske AJ, Srisuknimit V, Kahne D, Walker S, Marks DS, Bernhardt TG, Rudner DZ, Kruse AC. 2018. Structure of the peptidoglycan polymerase RodA resolved by evolutionary coupling analysis. Nature 556:118–121. doi: 10.1038/nature25985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Nygaard R, Graham CLB, Belcher Dufrisne M, Colburn JD, Pepe J, Hydorn MA, Corradi S, Brown CM, Ashraf KU, Vickery ON, Briggs NS, Deering JJ, Kloss B, Botta B, Clarke OB, Columbus L, Dworkin J, Stansfeld PJ, Roper DI, Mancia F. 2023. Structural basis of peptidoglycan synthesis by E. coli RodA-PBP2 complex. Nat Commun 14:5151. doi: 10.1038/s41467-023-40483-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Meeske AJ, Riley EP, Robins WP, Uehara T, Mekalanos JJ, Kahne D, Walker S, Kruse AC, Bernhardt TG, Rudner DZ. 2016. SEDS proteins are a widespread family of bacterial cell wall polymerases. Nature 537:634–638. doi: 10.1038/nature19331 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Straume D, Piechowiak KW, Olsen S, Stamsås GA, Berg KH, Kjos M, Heggenhougen MV, Alcorlo M, Hermoso JA, Håvarstein LS. 2020. Class A PBPs have A distinct and unique role in the construction of the pneumococcal cell wall. Proc Natl Acad Sci USA 117:6129–6138. doi: 10.1073/pnas.1917820117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Graham CLB, Newman H, Gillett FN, Smart K, Briggs N, Banzhaf M, Roper DI. 2021. Dynamic network of proteins facilitate cell envelope biogenesis in gram-negative bacteria. Int J Mol Sci 22:12831. doi: 10.3390/ijms222312831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Walter A, Mayer C. 2019. Peptidoglycan structure, biosynthesis, and dynamics during bacterial growth. In Cohen E, Merzendorfer H (ed), Extracellular Sugar-Based Biopolymers Matricies. Springer Nature, Switzerland. [Google Scholar]
  • 29. Mohammadi T, Karczmarek A, Crouvoisier M, Bouhss A, Mengin-Lecreulx D, den Blaauwen T. 2007. The essential peptidoglycan glycosyltransferase MurG forms a complex with proteins involved in lateral envelope growth as well as with proteins involved in cell division in Escherichia coli. Mol Microbiol 65:1106–1121. doi: 10.1111/j.1365-2958.2007.05851.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Laddomada F, Miyachiro MM, Jessop M, Patin D, Job V, Mengin-Lecreulx D, Le Roy A, Ebel C, Breyton C, Gutsche I, Dessen A. 2019. The MurG glycosyltransferase provides an oligomeric scaffold for the cytoplasmic steps of peptidoglycan biosynthesis in the human pathogen Bordetella pertussis. Sci Rep 9:4656. doi: 10.1038/s41598-019-40966-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Bhavsar AP, Erdman LK, Schertzer JW, Brown ED. 2004. Teichoic acid is an essential polymer in Bacillus subtilis that is functionally distinct from teichuronic acid. J Bacteriol 186:7865–7873. doi: 10.1128/JB.186.23.7865-7873.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. D’Elia MA, Millar KE, Beveridge TJ, Brown ED. 2006. Wall teichoic acid polymers are dispensable for cell viability in Bacillus subtilis. J Bacteriol 188:8313–8316. doi: 10.1128/JB.01336-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Jorgenson MA, Young KD. 2016. Interrupting biosynthesis of O antigen or the lipopolysaccharide core produces morphological defects in Escherichia coli by sequestering undecaprenyl phosphate. J Bacteriol 198:3070–3079. doi: 10.1128/JB.00550-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Jorgenson MA, Kannan S, Laubacher ME, Young KD. 2016. Dead-end intermediates in the enterobacterial common antigen pathway induce morphological defects in Escherichia coli by competing for undecaprenyl phosphate. Mol Microbiol 100:1–14. doi: 10.1111/mmi.13284 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Barreteau H, Magnet S, El Ghachi M, Touzé T, Arthur M, Mengin-Lecreulx D, Blanot D. 2009. Quantitative high-performance liquid chromatography analysis of the pool levels of undecaprenyl phosphate and its derivatives in bacterial membranes. J Chromatogr B Analyt Technol Biomed Life Sci 877:213–220. doi: 10.1016/j.jchromb.2008.12.010 [DOI] [PubMed] [Google Scholar]
  • 36. Workman SD, Strynadka NCJ. 2020. A slippery scaffold: synthesis and recycling of the bacterial cell wall carrier lipid. J Mol Biol 432:4964–4982. doi: 10.1016/j.jmb.2020.03.025 [DOI] [PubMed] [Google Scholar]
  • 37. Hartley MD, Imperiali B. 2012. At the membrane frontier: a prospectus on the remarkable evolutionary conservation of polyprenols and polyprenyl-phosphates. Arch Biochem Biophys 517:83–97. doi: 10.1016/j.abb.2011.10.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Belliveau NM, Chure G, Hueschen CL, Garcia HG, Kondev J, Fisher DS, Theriot JA, Phillips R. 2021. Fundamental limits on the rate of bacterial growth and their influence on proteomic composition. Cell Syst 12:924–944. doi: 10.1016/j.cels.2021.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Roney IJ, Rudner DZ. 2024. Bacillus subtilis uses the SigM signaling pathway to prioritize the use of its lipid carrier for cell wall synthesis. PLoS Biol 22:e3002589. doi: 10.1371/journal.pbio.3002589 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES